ABVC BioPharma, Inc.
ABVC
$0.911
$0.0354.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 159.82% | 94.38% | 55.26% | -115.66% | 92.12% |
| Total Depreciation and Amortization | -50.11% | -6.67% | 90.00% | -80.00% | 5,515.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,064.21% | -82.62% | 13.57% | 987.51% | -97.51% |
| Change in Net Operating Assets | 53.78% | 600.00% | -152.23% | 930.60% | -133.07% |
| Cash from Operations | -14.66% | 112.64% | -12.70% | 68.40% | 6.64% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 285.34% |
| Cash from Investing | -- | -- | -- | -- | 285.11% |
| Total Debt Issued | 526.34% | 100.00% | 100.00% | -91.20% | -- |
| Total Debt Repaid | 5.09% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -96.79% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | 1,414.32% | -108.78% | 2,848.42% | -69.36% | 115.15% |
| Foreign Exchange rate Adjustments | 103.67% | -99.48% | -28.86% | 15.54% | -175.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.23% | -92.84% | 107.98% | -114.44% | 30.12% |